MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacasi.2023.07.005

Медицинская библиотека · JACC. Asia · 2023

Liquid Nitrogen Cryoballoon Ablation System for Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Single-Arm Clinical Trial.

Nie Zhenning, Zhao Dongdong, Ren Zhongyuan, Hou Cody R, Su Xi, Deng Chenggang, Yao Yan, Tang Kai, Li Yigang, Fu Hua, Zeng Rui, Lu Zhibing, Li Hongbing, Su Hao, Xiao Fangyi, Xu Yawei, Ge Junbo

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Cryoballoon ablation (CBA) has emerged as an effective treatment for atrial fibrillation (AF).

OBJECTIVES

This study sought to assess the performance of a novel liquid nitrogen-driven CBA system and evaluate its safety and efficacy in the treatment of drug-resistant paroxysmal atrial fibrillation (PAF).

METHODS

This was a prospective multicenter single-arm clinical trial with 10 participating tertiary hospitals enrolling 176 patients with PAF. All participants received liquid nitrogen-driven CBA developed by the Cryofocus Medtech Company. Scheduled follow-up was performed before discharge and 3 months, 6 months, and 12 months after CBA. The primary endpoints were defined as 1) treatment success (freedom from antiarrhythmic drugs and atrial tachycardia at 12 months after CBA); and 2) immediate success rate of pulmonary vein isolation. The safety endpoint was the incidence of device- and procedure-related adverse events (AEs) and all-cause mortality.

RESULTS

A total of 172 participants were included, with an average age of 59.22 ± 9.25 years and 99 (57.56%) of them men. Immediate success rate was 97.67% (95% CI: 94.15%-99.36%) and 12-month treatment success rate was 82.56% (95% CI: 76.89%-88.23%), including a late recurrence rate of 13.61%. Incidences of device- and procedure-related AEs were 2.27% and 25.00%, respectively. Phrenic nerve palsy (PNP) occurred in 6 patients, of which 5 recovered during follow-up. Although the incidence of total severe AEs was 17.05%, including an all-cause mortality of 0.57%, only 1 case of permanent PNP was related to the CBA procedure.

CONCLUSIONS

This premarketing prospective multicenter single-arm clinical trial demonstrated that the liquid nitrogen cryoablation system is safe and effective in the treatment of PAF.

Для цитирования: Nie Zhenning, Zhao Dongdong, Ren Zhongyuan, Hou Cody R, Su Xi, Deng Chenggang, Yao Yan, Tang Kai, Li Yigang, Fu Hua, Zeng Rui, Lu Zhibing, Li Hongbing, Su Hao, Xiao Fangyi, Xu Yawei, Ge Junbo. Liquid Nitrogen Cryoballoon Ablation System for Paroxysmal Atrial Fibrillation: A Multicenter, Prospective, Single-Arm Clinical Trial.. JACC. Asia. 2023. DOI: 10.1016/j.jacasi.2023.07.005.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.